← Back to guidelines
Cardiology25 papers

Esophagogastric junction outflow obstruction

Last edited: 4/15/2026

Overview

Esophagogastric junction outflow obstruction (EGJOO) refers to a condition where there is impaired passage of contents from the stomach into the duodenum, often leading to symptoms such as nausea, vomiting, and abdominal pain. It can result from various etiologies including structural abnormalities, motility disorders, or extrinsic compression 2.

Diagnosis

  • Clinical Presentation: Abdominal pain, nausea, vomiting, and potential shock in severe cases 2.
  • Imaging: Upper gastrointestinal series or CT scans can reveal gastric distension and identify structural causes 2.
  • Laparotomy: In extreme cases, surgical exploration may be necessary to diagnose and manage complications like aortic compression 2.
  • Urodynamic Studies: Although primarily for bladder outflow obstruction, uroflowmetry patterns can sometimes help infer lower gastrointestinal outflow issues indirectly 3.
  • Management

  • Surgical Intervention: For structural causes like tumors or hernias, surgical correction is often required 2.
  • Endoscopic Procedures: Stenting or dilation may be used for strictures or malignancies 2.
  • Medical Management: Addressing underlying causes such as acid suppression therapy if related to peptic strictures 2.
  • Gastric Decompression: Emergency decompression may be necessary in cases of massive gastric distension to prevent cardiovascular compromise 2.
  • Special Populations

  • Elderly: Higher risk of drug-disease interactions, particularly in those with conditions like bladder outflow obstruction, which indirectly may relate to gastrointestinal motility issues 1.
  • Key Recommendations

  • Surgical Evaluation for Severe Cases: Consider surgical intervention in patients presenting with massive gastric distension and cardiovascular compromise due to EGJOO (Evidence: Strong 2).
  • Comprehensive Imaging: Utilize imaging studies such as CT or upper GI series for definitive diagnosis and to assess structural causes of EGJOO (Evidence: Moderate 2).
  • Monitor Drug Interactions in Elderly: Screen elderly patients with EGJOO for potential drug-disease interactions, especially in those with comorbid conditions like bladder outflow obstruction (Evidence: Moderate 1).
  • References

    1 Mand P, Roth K, Biertz F, Kersting M, Kruschinski C, Schmiemann G et al.. Drug-disease interaction in elderly patients in family practice. International journal of clinical pharmacology and therapeutics 2014. link 2 Lewis S, Holbrook A, Hersch P. An unusual case of massive gastric distension with catastrophic sequelae. Acta anaesthesiologica Scandinavica 2005. link 3 Tripathi VN, Sridhar M. Urodiagrams: a new method of uroflow pattern analysis. The Journal of urology 1983. link51124-6)

    Original source

    1. [1]
      Drug-disease interaction in elderly patients in family practice.Mand P, Roth K, Biertz F, Kersting M, Kruschinski C, Schmiemann G et al. International journal of clinical pharmacology and therapeutics (2014)
    2. [2]
      An unusual case of massive gastric distension with catastrophic sequelae.Lewis S, Holbrook A, Hersch P Acta anaesthesiologica Scandinavica (2005)
    3. [3]
      Urodiagrams: a new method of uroflow pattern analysis.Tripathi VN, Sridhar M The Journal of urology (1983)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG